Angiotensin-converting enzyme (ACE and ACE2) imbalance correlates with the severity of cerulein-induced acute pancreatitis in mice

Experimental Physiology

Volumn 99, Issue 4, 2014, Pages 651-663

  Liu, Ruixia ^a   Qi, Haiyu ^a   Wang, Jing ^a   Wang, Yan ^a   Cui, Lijian ^a   Wen, Yan ^a   Yin, Chenghong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN[1-7]; CERULETIDE; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; ANGIOTENSIN I; ANGIOTENSIN I (1-7); AUTACOID; BIOLOGICAL MARKER; PEPTIDE FRAGMENT;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; HISTOLOGY; INFLAMMATION; INFLAMMATORY INFILTRATE; KNOCKOUT MOUSE; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PANCREAS INJURY; PATHOGENESIS; PROTEIN EXPRESSION; SURVIVAL RATE; TRANSGENIC MOUSE; WILD TYPE; ACUTE DISEASE; ANIMAL; BLOOD; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; GENETICS; GENOTYPE; METABOLISM; NECROSIS; PANCREAS; PANCREATITIS; PATHOLOGY; PHENOTYPE; SEVERITY OF ILLNESS INDEX; TIME;

ACUTE DISEASE; AMYLASES; ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; BIOLOGICAL MARKERS; CERULETIDE; DISEASE MODELS, ANIMAL; GENOTYPE; INFLAMMATION MEDIATORS; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; NECROSIS; PANCREAS; PANCREATITIS; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84897395577     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2013.074815     Document Type: Article

References (46)

1. Batlle D, Jose SM & Ye M (2010). ACE2 and diabetes: ACE of ACEs? Diabetes 59, 2994-2996.
2. Bindom SM, Hans CP, Xia H, Boulares AH & Lazartigues E (2010). Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice. Diabetes 59, 2540-2548.
3. Bindom SM & Lazartigues E (2009). The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol 302, 193-202.
4. Burrell LM, Harrap SB, Velkoska E & Patel SK (2013). The ACE2 gene: its potential as a functional candidate for cardiovascular disease. Clin Sci (Lond) 124, 65-76.
5. Byrnes JJ, Gross S, Ellard C, Connolly K, Donahue S & Picarella D (2009). Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice. Inflamm Res 58, 819-827.
6. Chan YC & Leung PS (2009). Involvement of redox-sensitive extracellular-regulated kinases in angiotensin II-induced interleukin-6 expression in pancreatic acinar cells. J Pharmacol Exp Ther 329, 450-458.
7. Chan YC & Leung PS (2011a). Co-operative effects of angiotensin II and caerulein in NFκB activation in pancreatic acinar cells in vitro. Regul Pept 166, 128-134.
8. Chan YC & Leung PS (2011b). The renin-angiotensin system and reactive oxygen species: implications in pancreatitis. Antioxid Redox Signal 15, 2743-2755.
9. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, da Costa J, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Backx PH, Yagil Y & Penninger JM (2002). Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417, 822-828.
10. Ding SP, Li JC & Jin C (2003). A mouse model of severe acute pancreatitis induced with caerulein and lipopolysaccharide. World J Gastroenterol 9, 584-589.
11. Ernsberger P & Koletsky RJ (2007). Metabolic actions of angiotensin receptor antagonists: PPAR-γ agonist actions or a class effect. Curr Opin Pharmacol 7, 140-145.
12. Fang HJ & Yang JK (2010). Tissue-specific pattern of angiotensin-converting enzyme 2 expression in rat pancreas. J Int Med Res 38, 558-569.
13. Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, Sigl V, Hanada T, Hanada R, Lipinski S, Wild B, Camargo SM, Singer D, Richter A, Kuba K, Fukamizu A, Schreiber S, Clevers H, Verrey F, Rosenstiel P & Penninger JM (2012). ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487, 477-481.
14. Hidalgo M, Martin-Santamaria S, Recio I, Sanchez-Moreno C, de Pascual-Teresa B, Rimbach G & de Pascual-Teresa S (2012). Potential anti-inflammatory, anti-adhesive, anti/estrogenic, and angiotensin-converting enzyme inhibitory activities of anthocyanins and their gut metabolites. Genes Nutr 7, 295-306.
15. Ju KD, Lim JW, Kim KH & Kim H (2011). Potential role of NADPH oxidase-mediated activation of Jak2/Stat3 and mitogen-activated protein kinases and expression of TGF-β1 in the pathophysiology of acute pancreatitis. Inflamm Res 60, 791-800.
16. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C & Penninger JM (2005). A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 11, 875-879.
17. Kuno A, Yamada T, Masuda K, Ogawa K, Sogawa M, Nakamura S, Nakazawa T, Ohara H, Nomura T, Joh T, Shirai T & Itoh M (2003). Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Gastroenterology 124, 1010-1019.
18. Lau ST & Leung PS (2011). Role of the RAS in pancreatic cancer. Curr Cancer Drug Targets 11, 412-420.
19. Li N, Zimpelmann J, Cheng K, Wilkins JA & Burns KD (2005). The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules. Am J Physiol Renal Physiol 288, F353-F362.
20. Liu WB, Wang XP, Wu K & Zhang RL (2005). Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells. World J Gastroenterol 11, 6489-6494.
21. Merkle M & Grone HJ (2012). Interstitial nephritis and autoimmune pancreatitis: a case report. Int Urol Nephrol 44, 319-322.
22. Niu MJ, Yang JK, Lin SS, Ji XJ & Guo LM (2008). Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice. Endocrine 34, 56-61.
23. Ohashi S, Nishio A, Nakamura H, Kido M, Ueno S, Uza N, Inoue S, Kitamura H, Kiriya K, Asada M, Tamaki H, Matsuura M, Kawasaki K, Fukui T, Watanabe N, Nakase H, Yodoi J, Okazaki K & Chiba T (2006). Protective roles of redox-active protein thioredoxin-1 for severe acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 290, G772-G781.
24. Ohishi M, Yamamoto K & Rakugi H (2013). Angiotensin (1-7) and other angiotensin peptides. Curr Pharm Des 19, 3060-3064.
25. Oruc N, Ozutemiz O, Nart D, Yuce G, Celik HA & Ilter T (2010). Inhibition of renin-angiotensin system in experimental acute pancreatitis in rats: a new therapeutic target? Exp Toxicol Pathol 62, 353-360.
26. Paizis G, Tikellis C, Cooper ME, Schembri JM, Lew RA, Smith AI, Shaw T, Warner FJ, Zuilli A, Burrell LM & Angus PW (2005). Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 54, 1790-1796.
27. Paul M, Poyan MA & Kreutz R (2006). Physiology of local renin-angiotensin systems. Physiol Rev 86, 747-803.
28. Reis AB, Araújo FC, Pereira VM, Dos Reis AM, Santos RA & Reis FM (2010). Angiotensin (1-7) and its receptor Mas are expressed in the human testis: implications for male infertility. J Mol Histol 41, 75-80.
29. Rey-Parra GJ, Vadivel A, Coltan L, Hall A, Eaton F, Schuster M, Loibner H, Penninger JM, Kassiri Z, Oudit GY & Thébaud B (2012). Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury. J Mol Med (Berl) 90, 637-647.
30. Sakurai T, Kudo M, Fukuta N, Nakatani T, Kimura M, Park AM & Munakata H (2011). Involvement of angiotensin II and reactive oxygen species in pancreatic fibrosis. Pancreatology 11 Suppl 2, 7-13.
31. Shi Y, Zhang B, Chen XJ, Xu DQ, Wang YX, Dong HY, Ma SR, Sun RH, Hui YP & Li ZC (2013). Osthole protects lipopolysaccharide-induced acute lung injury in mice by preventing down-regulation of angiotensin-converting enzyme 2. Eur J Pharm Sci 48, 819-824.
32. Simões e Silva AC, Silveira KD, Ferreira AJ & Teixeira MM (2013). ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol 169, 477-492.
33. Sjöberg BT, García Rodríguez LA & Lindblad M (2009). Use of angiotensin II receptor blockers and the risk of acute pancreatitis: a nested case-control study. Pancreatology 9, 786-792.
34. Sriramula S, Cardinale JP, Lazartigues E & Francis J (2011). ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc Res 92, 401-408.
35. Suski M, Gebska A, Olszanecki R, Stachowicz A, Uracz D, Madej J & Korbut R (2013). Influence of atorvastatin on angiotensin I metabolism in resting and TNF-α-activated rat vascular smooth muscle cells. J Renin Angiotensin Aldosterone Syst, doi:10.1177/1470320313475907.
36. Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC & Cooper ME (2004). Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat. Diabetes 53, 989-997.
37. Tsang SW, Cheng CH & Leung PS (2004a). The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis. Regul Pept 119, 213-219.
38. 2 receptor antagonists and their effects on changes in the severity of pancreatitis. Int J Biochem Cell Biol 36, 330-339.
39. Tsang SW, Ip SP, Wong TP, Che CT & Leung PS (2003). Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis. Regul Pept 111, 47-53.
40. Ulmasov B, Xu Z, Talkad V, Oshima K & Neuschwander-Tetri BA (2010). Angiotensin II signaling through the AT1a and AT1b receptors does not have a role in the development of cerulein-induced chronic pancreatitis in the mouse. Am J Physiol Gastrointest Liver Physiol 299, G70-G80.
41. Wang Y, Wang J, Liu R, Qi H, Wen Y, Sun F & Yin C (2012). Severe acute pancreatitis is associated with upregulation of the ACE2-angiotensin-(1-7)-Mas axis and promotes increased circulating angiotensin-(1-7). Pancreatology 12, 451-457.
42. Wysocki J, Ye M, Soler MJ, Gurley SB, Xiao HD, Bernstein KE, Coffman TM, Chen S & Batlle D (2006). ACE and ACE2 activity in diabetic mice. Diabetes 55, 2132-2139.
43. Yang XH, Wang YH, Wang JJ, Liu YC, Deng W, Qin C, Gao JL, Zhang LY (2012). Role of angiotensin-converting enzyme (ACE and ACE2) imbalance on tourniquet-induced remote kidney injury in a mouse hindlimb ischemia-reperfusion model. Peptides 36, 60-70.
44. Ye M, Wysocki J, William J, Soler MJ, Cokic I & Batlle D (2006). Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 17, 3067-3075.
45. Yi ET, Liu RX, Wen Y & Yin CH (2012). Telmisartan attenuates hepatic fibrosis in bile duct-ligated rats. Acta Pharmacol Sin 33, 1518-1524.
46. Zhong J, Guo D, Chen CB, Wang W, Schuster M, Loibner H, Penninger JM, Scholey JW, Kassiri Z & Oudit GY (2011). Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. Hypertension 57, 314-322.